BOMI ITALIA : S.P.A. – BOMI GROUP KEY CONSOLIDATED FIGURES AT 30 JUNE 2018

Bomi Italia S.p.A.

- PRESS RELEASE -

Bomi Group key consolidated figures at 30 June 2018

Vaprio d'Adda, 19 September 2018 - Bomi Italia S.p.A. ("Bomi" or the "Company" or the "Issuer"), Parent Company of the Bomi Group, a world leader in the biomedical logistics sector and in the management of high technology healthcare products, which is listed on the multilateral trading platform of AIM Italia / Alternative Capital Market, regulated and managed by Borsa Italiana S.p.A., given the forthcoming presentation of the Issuer on 21 September 2018 as part of the LUGANO SMALL & MID CAP INVESTOR DAY, communicates that the Board of Directors, also in order to provide the latest figures in its presentation at the aforementioned event, has examined the key consolidated figures at 30 June 2018.

The consolidated value of production at 30 June 2018 was approximately Euro 62 million, an increase of approximately 6% compared to the figure for the first half 2017 of Euro 58.6 million. Using the same Euro exchange rates as in the first half 2017, the increase would have been approximately 15%: ca. 6% due to organic growth and the remaining ca. 9% from the consolidation of De Salute S.r.l., a company specialising in logistics for biotech, pharmaceutical and health technology products that was acquired by Bomi in January 2018. Moreover the consolidated value of production at 30 June 2018 is approximately 2% higher than the forecasts in the Group 2018 - 2020 Plan approved and published on 22 January 2018.

Consolidated gross operating profit (EBITDA) at 30 June 2018 was approximately Euro 5.5 million (ca. 8.8% of consolidated value of production at 30 June 2018) net of extraordinary and non-recurring items; using the Euro exchange rates prevailing at 30 June 2017, this figure would have exceeded Euro 6 million (approximately 9.3% of consolidated value of production at 30 June 2018 using the same exchange rates as at 30 June 2017); this would have implied growth of ca. 11% compared to the figure of Euro 5.6 million in the first half 2017. Consolidated EBITDA at 30 June 2018 was approximately 4% higher than the consolidated EBITDA figure in the 2018 - 2020 Plan.

Consolidated net profit at 30 June 2018 was approximately Euro 1.2 million of which 96% was attributable to the group. Using the Euro exchange rates prevailing in 2017, the consolidated net profit at 30 June 2018 would have been ca. Euro 1.5 million compared to the figure of Euro 1.56 million at 30 June 2017 (of which Euro 0.9 million was attributable to the group). The net profit exceeded the forecast in the 2018 - 2020 Plan.

The Consolidated net financial position at 30 June 2018 was approximately Euro 29.5 million compared to the figure of Euro 25.5 million at 31 December 2017.

The table below shows the change in the net financial position at 30 June 2018 which was mainly due to:

• - Investments in the first half 2018 which amounted to ca. Euro 3 million for investments made as part of management operations to set up and maintain the operating premises and Euro 4.6 million for M&A transactions that were the acquisition of De Salute and those of the non-controlling interests in the subsidiaries in Colombia and the Netherlands.

• - In the first semester 2018, Bomi also successfully concluded a Share Capital Increase, which was fully subscribed and closed on 1 June 2018. For Euro 4,7 million (net of expenses incurred).

The change in working capital partly reflects the natural effect of the increase in revenues but also

the regular increase in the entry "Other assets" in the first semester of every year due primarily to expenses, such as insurance premiums and advance payments of rents for warehouse, for future periods but which have a financial effect on the first semester.

The breakdown of the net financial position at 30 June 2018 was as follows:

The following table shows the maturities of the aforementioned non-convertible financial debt:

It should be noted from the illustration that all repayments until 2020 are completely covered by the liquidity available at 30 June 2018.

The Bomi Group therefore continues to grow as does its ongoing commitment to realise synergies in order to improve profitability.

The legal audit of the accounting figures given in this press release has yet to be completed and the full legally audited financial statements for the first semester 2018 will be discussed and approved at the next Board meeting on 28 September 2018 as specified in the financial timetable.

___________________________________________________________________________________________________

Bomi Italia S.p.A. is the Parent Company of Bomi Group, a world leader in the biomedical logistics sector and in the management of high technology healthcare products. It was one of the first companies to receive the "Elite" certificate issued by Borsa Italiana.

Bomi Group's activities are concentrated in the integrated logistics sector and offer a wide range of logistics services in outsourcing to companies operating in the healthcare sector, managing distribution of medical equipment, pharmaceuticals, in-vitro diagnostic equipment, reagents and implant products.

Bomi Group's portfolio of about 100 clients includes some of the world's top healthcare companies (such as the leading pharmaceutical companies and producers of healthcare devices) as well as small and medium sized companies operating at a global level in the biomedical, diagnostics and biotech industries. Bomi Group currently has about 1,235 employees and operates through subsidiary companies and associated companies in Europe, South America, China and the United States and its services are also provided, through strategic alliances with local partners.

ISIN Ordinary Share Code: IT0005108748 - Ordinary Share Ticker: BOMI

ISIN Convertible Bond Code: IT0005114480 - Convertible Bond Ticker: BOMI20

For further information.

Bomi Italia S.p.A. ●	IR Top	BPER Banca S.p.A. ●
Investor Relations	IR & Financial Communication	Nominated Adviser
tel: [phone]	Tel. [phone]	tel: [phone]
e.mail:[e-mail]	Email: @[e-mail]	e.mail:[e-mail]